Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease Activity, Prognosis, and Prediction of Response to Therapy

There exists a major unmet need for biomarkers that can identify axial spondyloarthritis (axSpA) early after disease onset because of the availability of highly effective therapies. Several recent reports have examined the autoantibody response in patients with axSpA through the use of protein micro...

Descripción completa

Detalles Bibliográficos
Autor principal: Maksymowych, Walter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416369/
https://www.ncbi.nlm.nih.gov/pubmed/30899255
http://dx.doi.org/10.3389/fimmu.2019.00305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416369/
https://www.ncbi.nlm.nih.gov/pubmed/30899255
http://dx.doi.org/10.3389/fimmu.2019.00305

Ejemplares similares